ATE426635T1 - Arzneimittelverabreichung - Google Patents
ArzneimittelverabreichungInfo
- Publication number
- ATE426635T1 ATE426635T1 AT03748273T AT03748273T ATE426635T1 AT E426635 T1 ATE426635 T1 AT E426635T1 AT 03748273 T AT03748273 T AT 03748273T AT 03748273 T AT03748273 T AT 03748273T AT E426635 T1 ATE426635 T1 AT E426635T1
- Authority
- AT
- Austria
- Prior art keywords
- drug administration
- relates
- drugs
- delivery
- solubilising
- Prior art date
Links
- 238000001647 drug administration Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0206—Polyalkylene(poly)amines
- C08G73/0213—Preparatory process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0206—Polyalkylene(poly)amines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0206—Polyalkylene(poly)amines
- C08G73/0213—Preparatory process
- C08G73/0226—Quaternisation of polyalkylene(poly)amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0221942.6A GB0221942D0 (en) | 2002-09-20 | 2002-09-20 | Drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE426635T1 true ATE426635T1 (de) | 2009-04-15 |
Family
ID=9944516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03748273T ATE426635T1 (de) | 2002-09-20 | 2003-09-22 | Arzneimittelverabreichung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060148982A1 (de) |
| EP (1) | EP1543063B1 (de) |
| JP (1) | JP2006500437A (de) |
| AT (1) | ATE426635T1 (de) |
| AU (1) | AU2003267581A1 (de) |
| CA (1) | CA2499681A1 (de) |
| DE (1) | DE60326859D1 (de) |
| DK (1) | DK1543063T3 (de) |
| GB (1) | GB0221942D0 (de) |
| SI (1) | SI1543063T1 (de) |
| WO (1) | WO2004026941A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0422877D0 (en) * | 2004-10-14 | 2004-11-17 | Univ Glasgow | Bioactive polymers |
| US8057821B2 (en) * | 2004-11-03 | 2011-11-15 | Egen, Inc. | Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof |
| JP5027157B2 (ja) | 2006-01-19 | 2012-09-19 | オールエクセル，インコーポレイティド | 自己集合性の両親媒性ポリマーを有する薬物の可溶化および標的化導入 |
| AU2007209376B2 (en) * | 2006-01-27 | 2013-02-07 | Basf Se | Polymeric anti-microbial agents |
| US20090263346A1 (en) * | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
| US8956602B2 (en) * | 2006-12-05 | 2015-02-17 | Landec, Inc. | Delivery of drugs |
| US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
| US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
| US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
| PL2126020T3 (pl) * | 2006-12-22 | 2012-04-30 | Basf Se | Hydrofobowo modyfikowane polialkilenoiminy jako inhibitory przenoszenia barwnika |
| CN101795695B (zh) * | 2007-07-19 | 2016-01-06 | 阿列克斯塞尔公司 | 作为抗癌剂的自组装的两亲性聚合物 |
| US8114883B2 (en) * | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
| FR2928373B1 (fr) | 2008-03-05 | 2010-12-31 | Centre Nat Rech Scient | Polymere derive de la polyethylenimine lineaire pour le transfert de gene. |
| GB0903559D0 (en) | 2009-03-02 | 2009-04-08 | Univ London Pharmacy | Oral delivery of hydrophilic drugs to the brain |
| EP2424581B1 (de) | 2009-04-28 | 2017-03-01 | SurModics, Inc. | Vorrichtungen und verfahren zur abgabe von biologisch wirksamen mitteln |
| GB0915449D0 (en) | 2009-09-04 | 2009-10-07 | Univ Robert Gordon | Composition |
| DK2563843T3 (en) | 2010-04-28 | 2018-03-12 | Univ Georgia | PHOTOCHEMICAL CROSS-POLYMERS, PROCEDURES FOR MARKING PHOTOCHEMIC CROSS-POLYMERS, PROCEDURES FOR USING PHOTOCHEMIC CROSS-POLYMERS, AND ... |
| US8721936B2 (en) | 2011-04-21 | 2014-05-13 | University Of Georgia Research Foundation, Inc. | Devices and methods for forming non-spherical particles |
| US10213529B2 (en) | 2011-05-20 | 2019-02-26 | Surmodics, Inc. | Delivery of coated hydrophobic active agent particles |
| US9861727B2 (en) | 2011-05-20 | 2018-01-09 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
| CA2841000C (en) | 2011-07-15 | 2020-02-25 | University Of Georgia Research Foundation, Inc. | Permanent attachment of agents to surfaces containing c-h functionality |
| WO2013019918A2 (en) | 2011-08-04 | 2013-02-07 | The University Of Georgia Research Foundation, Inc. | Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing-oh functionality |
| US9839213B2 (en) | 2011-10-14 | 2017-12-12 | The University Of Georgia Research Foundation, Inc. | Photochemical cross-linkable polymers, methods of making photochemical cross-linkable polymers, methods of using photochemical cross-linkable polymers, and methods of making articles containing photochemical cross-linkable polymers |
| WO2014071387A1 (en) | 2012-11-05 | 2014-05-08 | Surmodics, Inc. | Composition and method for delivery of hydrophobic active agents |
| US11246963B2 (en) | 2012-11-05 | 2022-02-15 | Surmodics, Inc. | Compositions and methods for delivery of hydrophobic active agents |
| US10898446B2 (en) | 2016-12-20 | 2021-01-26 | Surmodics, Inc. | Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces |
| US12226552B2 (en) | 2019-09-30 | 2025-02-18 | Surmodics, Inc. | Active agent depots formed in situ |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5879022A (ja) * | 1981-11-04 | 1983-05-12 | Bitamin Kenkyusho:Kk | 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤 |
| US5338532A (en) * | 1986-08-18 | 1994-08-16 | The Dow Chemical Company | Starburst conjugates |
| US5681543A (en) * | 1988-02-29 | 1997-10-28 | Shering Aktiengesellschaft | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI |
| JPH01236240A (ja) * | 1989-01-14 | 1989-09-21 | Miyoshi Oil & Fat Co Ltd | 新規な高分子化合物 |
| DE3901527A1 (de) * | 1989-01-20 | 1990-07-26 | Hoechst Ag | Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate |
| JP3406970B2 (ja) * | 1993-12-27 | 2003-05-19 | ミヨシ油脂株式会社 | 両性界面活性剤 |
| JP3526661B2 (ja) * | 1995-06-23 | 2004-05-17 | ミヨシ油脂株式会社 | 抗菌剤、抗菌性樹脂及び抗菌性塗料 |
| BR9709830A (pt) * | 1996-06-19 | 1999-08-10 | Procter & Gamble | Perocesso para remoção de maus cheiros de poliaminas modificadas |
| WO1999043752A1 (fr) * | 1998-02-27 | 1999-09-02 | Dnavec Research Inc. | Compositions pour transporter des substances chargees negativement |
| JP3523821B2 (ja) * | 2000-02-09 | 2004-04-26 | ナノキャリア株式会社 | 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物 |
| US6696038B1 (en) * | 2000-09-14 | 2004-02-24 | Expression Genetics, Inc. | Cationic lipopolymer as biocompatible gene delivery agent |
| CN1479632A (zh) * | 2000-10-09 | 2004-03-03 | 用于将核酸导入细胞的复合物 | |
| DE10065710A1 (de) * | 2000-12-29 | 2002-07-04 | Bayer Ag | Arzneimittel enthaltend ein Polyamin als Wirksubstanz |
| GB0221941D0 (en) * | 2002-09-20 | 2002-10-30 | Univ Strathclyde | Polysoaps |
-
2002
- 2002-09-20 GB GBGB0221942.6A patent/GB0221942D0/en not_active Ceased
-
2003
- 2003-09-22 JP JP2004537295A patent/JP2006500437A/ja active Pending
- 2003-09-22 AT AT03748273T patent/ATE426635T1/de not_active IP Right Cessation
- 2003-09-22 CA CA002499681A patent/CA2499681A1/en not_active Abandoned
- 2003-09-22 US US10/528,602 patent/US20060148982A1/en not_active Abandoned
- 2003-09-22 AU AU2003267581A patent/AU2003267581A1/en not_active Abandoned
- 2003-09-22 DE DE60326859T patent/DE60326859D1/de not_active Expired - Lifetime
- 2003-09-22 WO PCT/GB2003/004036 patent/WO2004026941A1/en not_active Ceased
- 2003-09-22 EP EP03748273A patent/EP1543063B1/de not_active Expired - Lifetime
- 2003-09-22 SI SI200331599T patent/SI1543063T1/sl unknown
- 2003-09-22 DK DK03748273T patent/DK1543063T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1543063B1 (de) | 2009-03-25 |
| DE60326859D1 (de) | 2009-05-07 |
| EP1543063A1 (de) | 2005-06-22 |
| US20060148982A1 (en) | 2006-07-06 |
| SI1543063T1 (sl) | 2009-08-31 |
| AU2003267581A1 (en) | 2004-04-08 |
| AU2003267581A8 (en) | 2004-04-08 |
| JP2006500437A (ja) | 2006-01-05 |
| WO2004026941A1 (en) | 2004-04-01 |
| GB0221942D0 (en) | 2002-10-30 |
| DK1543063T3 (da) | 2009-05-18 |
| CA2499681A1 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE426635T1 (de) | Arzneimittelverabreichung | |
| EP2004172A4 (de) | Wirkstofffreisetzungsverfahren, strukturen und zusammensetzungen für nasolacrimales system | |
| EA200600877A1 (ru) | Наночастицы для доставки лекарств | |
| NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
| CY1111458T1 (el) | Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης | |
| WO2006008639A8 (en) | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody | |
| EP1513825A4 (de) | Antituberkulöses arzneimittel: zusammensetzungen und verfahren | |
| CY1118179T1 (el) | Φαρμακευτικη συνθεση | |
| BRPI0608297A2 (pt) | composições de lipossomos | |
| WO2006060547A3 (en) | Systems and methods for intra-oral drug delivery | |
| EA200401252A1 (ru) | Микрочастицы лекарственных веществ | |
| TNSN03137A1 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING LOW SOLUBILITY AND / OR ACID SENSITIVE DRUGS AND NEUTRALIZED ACID POLYMERS. | |
| HUE040046T2 (hu) | Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások | |
| EP1796629A4 (de) | Halbfester abgabeträger und pharmazeutische zusammensetzungen | |
| CY1110495T1 (el) | Χρηση ενος αγωνιστη υποδοχεα nmda για τη θεραπεια εμβοης που προκαλειται απο κοχλιακη διεγερτοτοξικοτητα | |
| UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
| DE602005010788D1 (de) | Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln | |
| DE60327693D1 (de) | Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff | |
| CY1105211T1 (el) | Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη | |
| MXPA05012358A (es) | Combinacion farmaceutica que comprende modafinilo y otra droga. | |
| EA200702522A1 (ru) | Система доставки лекарств в полость рта и способы ее применения | |
| BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
| DE60205905D1 (de) | Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit | |
| ATE434431T1 (de) | Pharmazeutische formulierungen mit kurzketten- sphingolipiden und ihre verwendung | |
| WO2005010022A3 (en) | Agonist polypeptide of receptor for zot and zonulin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |